Pfizer Special Drugs Into The Medical Insurance, 2300 Yuan / Box Has Been Used in 8 Provinces And Cities! The New Crown To Be Out Of The Question?

Please contact oscar.xiao@wecistanche.com for more information

this is already the fourth year since the discovery of the new crown. From the current measures of each country for the new crown epidemic, China's epidemic prevention work is still relatively in place. Even so, the erratic epidemic has brought all industries to a standstill, so countries are now in urgent need of a special drug for Neocrown.

Please click here to know more

On February 11, a message from the State Drug Administration gave everyone renewed hope. In accordance with the special drug approval procedures for emergency review and approval of Pfizer's import registration of drugs for the treatment of the new crown virus. Not only that, there are 8 provinces and cities in China put into use!

Cistanche can improve immunity

A. Pfizer Inc.

Founded in 1849, Pfizer Inc. has a history of 173 years. Pfizer's headquarters is located in New York, United States, and is a biopharmaceutical company. Early Pfizer is not focused on biopharmaceuticals, the main business is the production of chemical products, until the emergence of the Civil War, the company entered a rapid development.

As a result of supplying a large number of drugs to the military during the war, Pfizer completed its initial transformation and the main product became citric acid. With the discovery of penicillin, Pfizer became involved in the research of antibiotics and focused its corporate development on the field of antibiotics, developing fermentation technology when it established Pfizer's position in the industry. When the time came for World War II, Pfizer produced penicillin with its own unique fermentation technology, which was not only in large quantities but also produced at a lower cost compared to the market, which made him favored by the U.S. military. The company took advantage of this opportunity to begin expanding its commercial footprint and further enhancing its production and research and development of the drug.

It is easy to see that the history of Pfizer is related to the war, which brought enough benefits to support its rapid development. The success of the drugs developed by Pfizer since then, such as oxytetracycline, tetracycline, and piroxicam, has brought immeasurable economic benefits to the company. After its commercial success, Pfizer acquired Warner-Lambert and Farmacia and became the largest drug manufacturer in the United States in one fell swoop.

By now, Pfizer has become the most competitive multinational pharmaceutical company. Pfizer has been in China for a long time. In the 1980s, Pfizer started to enter the Chinese market and has been in China for more than 30 years. It has become the largest foreign pharmaceutical company in China. Its business includes vaccines and prescription drugs for oncology, inflammation, immunity, and many other fields. And what Pfizer has really done to make a splash in front of the public is its research into a new crown of potent drugs!

In 2020, Pfizer said it developed a new crown vaccine. After this news was announced, Pfizer pulled up in a straight line before the U.S. stock market, up 10.88% at $48.62 as of the close, with a market value of $26.8 billion, or about 170 billion yuan, up from the previous day. In one fell swoop, Pfizer was ranked 49th on the Forbes Global Enterprise 2000 list.

Canada, Japan, Israel, the United Kingdom, and many other countries have sent distress signals to Pfizer. Recently, China also approved the Pfizer vaccine project, the new crown effect drug began to flow into China.

Second, the new crown of special drugs

On March 17, the first batch of vaccines entering China was 21,200 boxes. This batch of drugs has been distributed to at least 8 provinces such as Jilin, Shanghai, Guangdong, Fujian, Jiangxi, Shandong, Zhejiang, and Guangxi to save the clinical front line of the new crown. In addition, according to the Zhejiang side of the report said it is likely that Zhejiang will be this batch of drugs into the medical insurance.

Because the price of 2300 yuan a box is not cheap, for ordinary families the price of such a box of medicine is likely to occupy a large part of their expenses this month, not to mention the family is not just one person, but the effect of the treatment of new crown is certainly worth the price.

According to clinical trial data released by Pfizer, patients treated with Paxlovid had an 89% reduction in hospitalization and 88% reduction in mortality within 5 days of symptom onset compared to the same dose group. The viral load in the body was reduced 10-fold and there were no reported cases of death within 28 days, compared to 1.6% in the same-dose group.

Behind the effective results, the $2,300 a box that the country got for us is actually cheaper compared to Pfizer's pricing for other countries during the same period. Pfizer Paxlovid is priced in the United States for a five-day course of treatment, during which the cost per person is about $3,467. So one has to ask after such an effective and expensive vaccine is administered, does it mean that you can no longer be affected by the new crown and can take off the mask for that matter?

In fact, it is not, and the vaccination patient is already suffering from a new crown, and the more serious the symptoms, the more effective the embodiment will be. Pfizer also did not publish the data on the use of this vaccine in healthy groups, so it is not recommended that people in a healthy state get vaccinated. Moreover, our vaccine is relatively stable, and the point where a breakthrough is needed is the lack of a drug to treat coronavirus more effectively.

Currently, every country in the world is in a moment of great concern about the progress of the new crown vaccine and medical drugs. If the epidemic is not controlled, it is undoubtedly slowly consuming the country, and Pfizer, a foreign company, is leading in this regard.

In China, pharmaceutical companies such as Junshi Biologicals, Frontier Biologicals, Genting Xinyao, and Centrum Pharmaceuticals are among the leading companies in drug development in the domestic market. For example, VV116 developed by Junshi Biologicals and Pucrutamide developed by Frontier Pharmaceuticals are the fastest progressing among the new crown oral drugs. It is believed that the data from their clinical trials will be available soon, and we hope that the data released will be the same as all human beings would like to see.

III. Summary

In summary, every good news we have received over the years in the fight against the New Guinea epidemic has signaled that we are getting closer and closer to clearing the epidemic. From the initial panic when the epidemic was discovered to today's slowly overcoming the difficulties in the development of new crown drugs, we are proving to everyone the efforts of researchers.

Cistanche is dedicated to improving people's immunity, once the immunity is enhanced for the body, it can decrease the chance of infecting the coronavirus.

The principle is Cistanche Polysaccharides and Verbascum glycosides can increase the enzyme activity of heart and brain tissues, enhance the phagocytic function of abdominal cells, and lymphocyte proliferation, so cistanche can largely decrease the chance of infecting the Omicron.

This article is edited by Wecistanche